Article
The effect of HLA-DQB1 alleles on virologic breakthroughs during chronic hepatitis B treatment with genetically low barrier drugs.
Clinics and research in hepatology and gastroenterology - 1 Sept 2013
Doganay Levent, Tuncer Ilyas, Katrinli Seyma, Enc Feruze Yilmaz, Ozturk Oguzhan, Colak Yasar, Ulasoglu Celal, Dinler Gizem
Abstract excerpt
BACKGROUND: Chronic hepatitis B treatment with oral antiviral drugs is a long course. During this course, antiviral resistance is a serious issue, particularly, if genetically low barrier drugs are in use. Host immunity is accepted to have an effect on antiviral resistance development. The earliest clinical sign of drug resistance is virologic breakthrough. In this study, we aimed to investigate the relation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.